IP Library Granted Patent US 9,320,765
Granted Patent B2
US 9,320,765 · App. 14/020,155 · Granted Apr 26, 2016

Bioeffective krill oil compositions

Inventors: Inge Bruheim (Volda, NO); Snorre Tilseth (Bergen, NO); Daniele Mancinelli (Orsta, NO)
Assignee: AKER BIOMARINE ANTARCTIC AS
A61K35/612A61K9/48A61K9/4858A61K31/122A61K31/20A61K31/202A61K31/23A61K31/235A61K31/683A61K31/685A61K45/06C11B3/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,320,765
App. No.
14/020,155
Granted
Apr 26, 2016
Kind
B2
Abstract

This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO 2 or CO 2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO 2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.

Claims (49)

1. A krill oil composition comprising Euphausia superba krill oil suitable for oral administration, said krill oil comprising greater than about 3% ether phospholipids w/w of said krill oil; from about 27% to 50% non-ether phospholipids w/w of said krill oil so that the amount of total phospholipids in the composition is from about 30% to 60% w/w of said krill oil; from about 20% to 50% triglycerides w/w of said krill oil, and astaxanthin esters in amount of greater than about 100 mg/kg of said krill oil.

2. The krill oil composition of claim 1 , wherein said krill oil contains greater than about 200 mg/kg astaxanthin esters.

3. The krill oil composition of claim 1 , wherein said krill oil contains greater than about 300 mg/kg astaxanthin esters.

4. The krill oil composition of claim 1 , wherein said krill oil contains greater than about 400 mg/kg astaxanthin esters.

5. The krill oil composition of claim 1 , wherein said krill oil comprises from about 20% to 35% omega-3 fatty acids as a percentage of total fatty acids in said composition.

6. The krill oil composition of claim 5 , wherein from about 70% to 95% of said omega-3 fatty acids are attached to said phospholipids.

7. The krill oil composition of claim 1 , wherein said krill oil is contained in a soft gel capsule.

8. The krill oil composition of claim 1 , wherein said krill oil composition comprises a plant phytonutrient.

9. The krill oil composition of claim 1 , wherein said krill oil comprises greater than about 4% w/w ether phospholipids.

10. The krill oil composition of claim 9 , wherein said krill oil comprises greater than about 200 mg/kg astaxanthin esters.

11. The krill oil composition of claim 9 , wherein said krill oil comprises greater than about 300 mg/kg astaxanthin esters.

12. The krill oil composition of claim 10 , wherein said krill oil comprises from about 20% to 35% omega-3 fatty acids as a percentage of total fatty acids in said composition.

13. The krill oil composition of claim 12 , wherein from about 70% to 95% of said omega-3 fatty acids are attached to said phospholipids.

14. The krill oil composition of claim 10 , wherein said krill oil comprises greater than about 400 mg/kg astaxanthin esters.

15. The krill oil composition of claim 14 , wherein said krill oil comprises from about 20% to 35% omega-3 fatty acids as a percentage of total fatty acids in said composition.

16. The krill oil composition of claim 15 , wherein from about 70% to 95% of said omega-3 fatty acids are attached to said phospholipids.

17. The krill oil composition of claim 11 , wherein said krill oil composition comprises a plant phytonutrient.

18. The krill oil composition of claim 1 , wherein said krill oil comprises greater than about 5% w/w ether phospholipids.

19. The krill oil composition of claim 18 , wherein said krill oil comprises greater than about 200 mg/kg astaxanthin esters.

20. The krill oil composition of claim 18 , wherein said krill oil comprises greater than about 300 mg/kg astaxanthin esters.

21. The krill oil composition of claim 19 , wherein said krill oil comprises from about 20% to 35% omega-3 fatty acids as a percentage of total fatty acids in said composition.

22. The krill oil composition of claim 21 , wherein from about 70% to 95% of said omega-3 fatty acids are attached to said phospholipids.

23. The krill oil composition of claim 15 , wherein said krill oil comprises greater than about 400 mg/kg astaxanthin esters.

24. The krill oil composition of claim 19 , wherein said krill oil composition comprises a plant phytonutrient.

25. Encapsulated krill oil comprising:

a capsule containing a safe and effective amount of Euphausia superba krill oil, said krill oil comprising greater than about 3% ether phospholipids w/w of said krill oil; from about 27% to 50% non-ether phospholipids w/w of said krill oil so that the amount of total phospholipids in the composition is from about 30% to 60% w/w of said krill oil; from about 20% to 50% triglycerides w/w of said krill oil, and astaxanthin esters in amount of greater than about 100 mg/kg of said krill oil.

26. The encapsulated krill oil of claim 25 , wherein said krill oil in said capsules contains greater than about 200 mg/kg astaxanthin esters.

27. The encapsulated krill oil of claim 25 , wherein said krill oil in said capsules contains greater than about 300 mg/kg astaxanthin esters.

28. The encapsulated krill oil of claim 25 , wherein said krill oil in said capsules contains greater than about 400 mg/kg astaxanthin esters.

29. The encapsulated krill oil of claim 25 , wherein said krill oil in said capsules comprises from about 20% to 35% omega-3 fatty acids as a percentage of total fatty acids in said composition.

30. The encapsulated krill oil of claim 29 , wherein from about 70% to 95% of said omega-3 fatty acids are attached to said phospholipids.

31. The encapsulated krill oil of claim 25 , wherein said capsule is a soft gel capsule.

32. The encapsulated krill oil of claim 25 , wherein said capsule further contains a plant phytonutrient.

33. The encapsulated krill oil of claim 25 , wherein said krill oil in said capsules comprises greater than about 4% w/w ether phospholipids.

34. The encapsulated krill oil of claim 33 , wherein said krill oil in said capsules comprises greater than about 200 mg/kg astaxanthin esters.

35. The encapsulated krill oil of claim 33 , wherein said krill oil in said capsules comprises greater than about 300 mg/kg astaxanthin esters.

36. The encapsulated krill oil of claim 34 , wherein said krill oil in said capsules comprises from about 20% to 35% omega-3 fatty acids as a percentage of total fatty acids in said composition.

37. The encapsulated krill oil of claim 36 , wherein from about 70% to 95% of said omega-3 fatty acids are attached to said phospholipids.

38. The encapsulated krill oil of claim 34 , wherein said krill oil in said capsules comprises greater than about 400 mg/kg astaxanthin esters.

39. The encapsulated krill oil of claim 38 , wherein said krill oil in said capsules comprises from about 20% to 35% omega-3 fatty acids as a percentage of total fatty acids in said composition.

40. The encapsulated krill oil of claim 39 , wherein from about 70% to 95% of said omega-3 fatty acids are attached to said phospholipids.

41. The encapsulated krill oil of claim 34 , wherein said capsule further contains a plant phytonutrient.

42. The encapsulated krill oil of claim 25 , wherein said krill oil in said capsules comprises greater than about 5% w/w ether phospholipids.

43. The encapsulated krill oil of claim 42 , wherein said krill oil in said capsules comprises greater than about 200 mg/kg astaxanthin esters.

44. The encapsulated krill oil of claim 42 , wherein said krill oil in said capsules comprises greater than about 300 mg/kg astaxanthin esters.

45. The encapsulated krill oil of claim 43 , wherein said krill oil in said capsules comprises from about 20% to 35% omega-3 fatty acids as a percentage of total fatty acids in said composition.

46. The encapsulated krill oil of claim 45 , wherein from about 70% to 95% of said omega-3 fatty acids are attached to said phospholipids.

47. The encapsulated krill oil of claim 43 , wherein said krill oil in said capsules comprise greater than about 400 mg/kg astaxanthin esters.

48. The encapsulated krill oil of claim 43 , wherein said capsule further contains a plant phytonutrient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2015
From: AKER BIOMARINE AS
To: AKER BIOMARINE ANTARCTIC AS
Reel/Frame 034734/0841 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2013
From: BRUHEIM, INGE; TILSETH, SNORRE; MANCINELLI, DANIELE
To: AKER BIOMARINE AS
Reel/Frame 031589/0465 →
Continuity (6)
Continuation 12057775 · Mar 28, 2008
Provisional Application 60920483 · Mar 28, 2007
Provisional Application 60975058 · Sep 25, 2007
Provisional Application 60983446 · Oct 29, 2007
Provisional Application 61024072 · Jan 28, 2008
Related Publication 20140010888A1 · Jan 9, 2014